• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver.慢性酒精摄入破坏了大鼠的胆固醇稳态:肝脏中低密度脂蛋白受体下调和胆固醇生物合成途径增强。
Alcohol Clin Exp Res. 2010 Mar 1;34(3):471-8. doi: 10.1111/j.1530-0277.2009.01111.x. Epub 2009 Dec 18.
2
Peroxisome Proliferator-activated receptor γ activation by ligands and dephosphorylation induces proprotein convertase subtilisin kexin type 9 and low density lipoprotein receptor expression.配体和去磷酸化诱导过氧化物酶体增殖物激活受体 γ 的激活,从而诱导蛋白水解酶枯草溶菌素 kexin 9 型和低密度脂蛋白受体的表达。
J Biol Chem. 2012 Jul 6;287(28):23667-77. doi: 10.1074/jbc.M112.350181. Epub 2012 May 16.
3
Targeting the proprotein convertase subtilisin/kexin type 9 for the treatment of dyslipidemia and atherosclerosis.针对枯草溶菌素转化酶 9 治疗血脂异常和动脉粥样硬化。
J Am Coll Cardiol. 2013 Oct 15;62(16):1401-8. doi: 10.1016/j.jacc.2013.07.056. Epub 2013 Aug 21.
4
Proprotein convertase subtilisin/kexin type 9 (PCSK9): hepatocyte-specific low-density lipoprotein receptor degradation and critical role in mouse liver regeneration.前蛋白转化酶枯草杆菌蛋白酶/kexin 9型(PCSK9):肝细胞特异性低密度脂蛋白受体降解及在小鼠肝脏再生中的关键作用。
Hepatology. 2008 Aug;48(2):646-54. doi: 10.1002/hep.22354.
5
[Electroacupuncture mitigates hyperlipidemia via improving cholesterol metabolism mediated by SCAP/SREBP-2 signaling in liver tissue in rats].[电针通过改善大鼠肝组织中由SCAP/SREBP-2信号介导的胆固醇代谢来减轻高脂血症]
Zhen Ci Yan Jiu. 2023 Apr 25;48(4):325-30. doi: 10.13702/j.1000-0607.20211243.
6
Proteasome inhibitor treatment reduced fatty acid, triacylglycerol and cholesterol synthesis.蛋白酶体抑制剂治疗可减少脂肪酸、三酰甘油和胆固醇的合成。
Exp Mol Pathol. 2012 Aug;93(1):26-34. doi: 10.1016/j.yexmp.2012.03.006. Epub 2012 Mar 16.
7
PCSK9 inhibition as a novel therapeutic target for alcoholic liver disease.PCSK9 抑制作为酒精性肝病的一种新的治疗靶点。
Sci Rep. 2019 Nov 20;9(1):17167. doi: 10.1038/s41598-019-53603-6.
8
Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK/SREBP-2/PCSK9/LDLR signalling pathway.康莱欣是一种新型蒽醌类化合物,通过激活 AMPK/SREBP-2/PCSK9/LDLR 信号通路来抑制脂质堆积。
Biomed Pharmacother. 2021 Jan;133:110802. doi: 10.1016/j.biopha.2020.110802. Epub 2020 Nov 14.
9
Synergic hypocholesterolaemic effect of n-3 PUFA and oestrogen by modulation of hepatic cholesterol metabolism in female rats.n-3多不饱和脂肪酸与雌激素通过调节雌性大鼠肝脏胆固醇代谢产生协同降胆固醇作用。
Br J Nutr. 2015 Dec 14;114(11):1766-73. doi: 10.1017/S0007114515003517. Epub 2015 Sep 21.
10
Chronic-binge ethanol feeding aggravates systemic dyslipidemia in mice, thereby accelerating hepatic fibrosis.慢性 binge 乙醇喂养会加重小鼠的系统性血脂异常,从而加速肝纤维化。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1148827. doi: 10.3389/fendo.2023.1148827. eCollection 2023.

引用本文的文献

1
Fertility-enhancing effects of oil on reproductive functions of male rats: A two-generation study.油对雄性大鼠生殖功能的生育增强作用:两代研究
Avicenna J Phytomed. 2025 Jan-Feb;15(1):816-837. doi: 10.22038/AJP.2024.24590.
2
Hepatoprotective Effect of Mycelium Powder on Alcohol-Induced Liver Damage.菌丝体粉对酒精性肝损伤的保护作用。
Nutrients. 2024 Oct 8;16(19):3406. doi: 10.3390/nu16193406.
3
Synthesis of Ganoderic Acids Loaded Zein-Chitosan Nanoparticles and Evaluation of Their Hepatoprotective Effect on Mice Given Excessive Alcohol.负载灵芝酸的玉米醇溶蛋白-壳聚糖纳米粒的合成及其对过量饮酒小鼠的肝保护作用评价
Foods. 2024 Aug 29;13(17):2760. doi: 10.3390/foods13172760.
4
Enlarged perivascular spaces in alcohol-related brain damage induced by dyslipidemia.脂代谢紊乱所致酒精性脑损伤的血管周围间隙扩大。
J Cereb Blood Flow Metab. 2024 Oct;44(10):1867-1880. doi: 10.1177/0271678X241251570. Epub 2024 May 3.
5
Human Precision-Cut Liver Slices: A Potential Platform to Study Alcohol-Related Liver Disease.人源精准肝切片:研究酒精性肝病的潜在平台。
Int J Mol Sci. 2023 Dec 21;25(1):150. doi: 10.3390/ijms25010150.
6
Chronic-binge ethanol feeding aggravates systemic dyslipidemia in mice, thereby accelerating hepatic fibrosis.慢性 binge 乙醇喂养会加重小鼠的系统性血脂异常,从而加速肝纤维化。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1148827. doi: 10.3389/fendo.2023.1148827. eCollection 2023.
7
System Biology Investigation Revealed Lipopolysaccharide and Alcohol-Induced Hepatocellular Carcinoma Resembled Hepatitis B Virus Immunobiology and Pathogenesis.系统生物学研究揭示脂多糖和酒精诱导的肝细胞癌类似于乙型肝炎病毒的免疫生物学和发病机制。
Int J Mol Sci. 2023 Jul 6;24(13):11146. doi: 10.3390/ijms241311146.
8
Dietary cholesterol in alcohol-associated liver disease.酒精性肝病中的膳食胆固醇。
Immunometabolism (Cobham). 2023 May 3;5(2):e00026. doi: 10.1097/IN9.0000000000000026. eCollection 2023 Apr.
9
Histopathological Changes in the Myocardium Caused by Energy Drinks and Alcohol in the Mid-term and Their Effects on Skeletal Muscle Following Ischemia-reperfusion in a Rat Model.能量饮料和酒精引起的心肌组织中期组织病理学变化及其对大鼠缺血再灌注后骨骼肌的影响。
Anatol J Cardiol. 2023 Jan;27(1):12-18. doi: 10.14744/AnatolJCardiol.2022.2003.
10
Caffeic acid dimethyl ether alleviates alcohol-induced hepatic steatosis via microRNA-378b-mediated CaMKK2-AMPK pathway.咖啡酸二甲醚通过 microRNA-378b 介导的 CaMKK2-AMPK 通路缓解酒精性肝脂肪变性。
Bioengineered. 2022 Apr;13(4):11122-11136. doi: 10.1080/21655979.2022.2060586.

本文引用的文献

1
The LDL receptor.低密度脂蛋白受体
Arterioscler Thromb Vasc Biol. 2009 Apr;29(4):431-8. doi: 10.1161/ATVBAHA.108.179564.
2
Enhanced free cholesterol, SREBP-2 and StAR expression in human NASH.人类非酒精性脂肪性肝炎中游离胆固醇、SREBP-2和StAR表达增强。
J Hepatol. 2009 Apr;50(4):789-96. doi: 10.1016/j.jhep.2008.12.016. Epub 2009 Jan 14.
3
Betaine administration corrects ethanol-induced defective VLDL secretion.给予甜菜碱可纠正乙醇诱导的极低密度脂蛋白(VLDL)分泌缺陷。
Mol Cell Biochem. 2009 Jul;327(1-2):75-8. doi: 10.1007/s11010-009-0044-2. Epub 2009 Feb 15.
4
PCSK9 as a therapeutic target of dyslipidemia.前蛋白转化酶枯草溶菌素9作为血脂异常的治疗靶点。
Expert Opin Ther Targets. 2009 Jan;13(1):19-28. doi: 10.1517/14728220802600715.
5
Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis.在非酒精性脂肪性肝炎的高脂血症小鼠模型中,膳食胆固醇而非肝脂肪变性会导致肝脏炎症。
Hepatology. 2008 Aug;48(2):474-86. doi: 10.1002/hep.22363.
6
Cholesterol and sphingolipids in alcohol-induced liver injury.胆固醇与鞘脂在酒精性肝损伤中的作用
J Gastroenterol Hepatol. 2008 Mar;23 Suppl 1:S9-15. doi: 10.1111/j.1440-1746.2007.05280.x.
7
PCSK9: an enigmatic protease.前蛋白转化酶枯草溶菌素9:一种神秘的蛋白酶。
Biochim Biophys Acta. 2008 Apr;1781(4):184-91. doi: 10.1016/j.bbalip.2008.01.003. Epub 2008 Feb 2.
8
Alcohol-induced steatosis in liver cells.酒精性肝细胞脂肪变性。
World J Gastroenterol. 2007 Oct 7;13(37):4974-8. doi: 10.3748/wjg.v13.i37.4974.
9
Activation of PPARalpha lowers synthesis and concentration of cholesterol by reduction of nuclear SREBP-2.过氧化物酶体增殖物激活受体α(PPARα)的激活通过降低核内固醇调节元件结合蛋白-2(SREBP-2)来降低胆固醇的合成和浓度。
Biochem Pharmacol. 2007 Feb 15;73(4):574-85. doi: 10.1016/j.bcp.2006.10.027. Epub 2006 Nov 10.
10
Cholesterol sensing, trafficking, and esterification.胆固醇的感知、运输与酯化
Annu Rev Cell Dev Biol. 2006;22:129-57. doi: 10.1146/annurev.cellbio.22.010305.104656.

慢性酒精摄入破坏了大鼠的胆固醇稳态:肝脏中低密度脂蛋白受体下调和胆固醇生物合成途径增强。

Chronic alcohol consumption disrupted cholesterol homeostasis in rats: down-regulation of low-density lipoprotein receptor and enhancement of cholesterol biosynthesis pathway in the liver.

机构信息

Department of Human Nutrition, University of Illinois at Chicago, Illinois 60612, USA.

出版信息

Alcohol Clin Exp Res. 2010 Mar 1;34(3):471-8. doi: 10.1111/j.1530-0277.2009.01111.x. Epub 2009 Dec 18.

DOI:10.1111/j.1530-0277.2009.01111.x
PMID:20028367
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260025/
Abstract

BACKGROUND

Chronic alcohol consumption causes alcoholic liver disease, which is associated, or initiated, with dysregulated lipid metabolism. Very recent evidence suggested that dysregulated cholesterol metabolism plays an important role in the pathogenesis of alcoholic fatty liver diseases, however, the effects of chronic alcohol exposure on cholesterol homeostasis have not been well studied and underlying mechanisms behind are still elusive.

METHODS

Male Sprague-Dawley rats weighing 250 +/- 5.5 g (mean +/- SEM) divided into 2 groups (8 rats per group) and pair-fed with liquid diets containing (in percent of energy intake) 18% protein, 35% fat, 12% carbohydrate, and 35% either ethanol (ethanol diet) or an isocaloric maltose-dextrin mixture (control diet), according to Lieber and De Carli, for 4 weeks.

RESULTS

Long-term excessive alcohol feeding to rats caused fatty liver and liver injury, which was associated with disrupted cholesterol homeostasis, characterized by increased hepatic cholesterol levels and hypercholesterolemia. Hepatic cholesterol increases were concomitant with constantly activated sterol regulatory element-binding protein-2 (SREBP-2) in the liver and increased expression of 3-hydroxy-3-methyl-glutaryl-CoA (HMG-CoA) reductase, a rate-limiting enzyme for cholesterol de novo synthesis, indicating enhanced cholesterol biosynthesis. Alcohol-induced hypercholesterolemia was accompanied by decreased LDL receptor (LDLr) levels in the liver. Further investigations revealed that chronic alcohol exposure increased hepatic proprotein convertase subtilisin/kexin type 9 (PCSK9) contents to down-regulate LDLr via a post-translational mechanism. Moreover, alcohol feeding suppressed extracellular signal-regulated kinase (ERK) activation in the liver. In vitro studies showed that inhibition of ERK activation was associated with decreased LDLr expression in HepG2 cells.

CONCLUSIONS

Our study provides the first evidence that both increased PCSK9 expression and suppressed ERK activation in the liver contributes to alcohol-induced hypercholesterolemia in rats.

摘要

背景

慢性酒精摄入会导致酒精性肝病,而后者与脂质代谢失调有关,或由其引发。最近的证据表明,胆固醇代谢失调在酒精性脂肪肝疾病的发病机制中起着重要作用,然而,慢性酒精暴露对胆固醇稳态的影响尚未得到很好的研究,其潜在机制仍不清楚。

方法

雄性 Sprague-Dawley 大鼠体重 250 ± 5.5 g(平均值 ± SEM),分为 2 组(每组 8 只大鼠),并根据 Lieber 和 De Carli 的方法,用含有(占能量摄入的百分比)18%蛋白质、35%脂肪、12%碳水化合物和 35%乙醇(乙醇饮食)或等热量麦芽糊精混合物(对照饮食)的液体饮食进行喂养 4 周。

结果

长期过量饮酒会导致大鼠脂肪肝和肝损伤,这与胆固醇稳态失调有关,其特征为肝胆固醇水平升高和高胆固醇血症。肝胆固醇的增加与肝中固醇调节元件结合蛋白-2(SREBP-2)的持续激活以及 3-羟基-3-甲基戊二酰辅酶 A(HMG-CoA)还原酶的表达增加有关,HMG-CoA 还原酶是胆固醇从头合成的限速酶,表明胆固醇生物合成增强。酒精引起的高胆固醇血症伴随着肝内 LDL 受体(LDLr)水平的降低。进一步的研究表明,慢性酒精暴露会增加肝前蛋白转化酶枯草杆菌蛋白酶/kexin 9 型(PCSK9)的含量,通过翻译后机制下调 LDLr。此外,酒精喂养抑制了肝外信号调节激酶(ERK)的激活。体外研究表明,ERK 激活的抑制与 HepG2 细胞中 LDLr 表达的降低有关。

结论

我们的研究首次提供了证据表明,肝脏中 PCSK9 表达的增加和 ERK 激活的抑制都有助于大鼠酒精性高胆固醇血症的发生。